Monday May 29th 2017

[Comment] New treatments for multiple sclerosis: at what long-term risk?

Since 1993, eight different classes of disease-modifying therapies for relapsing-remitting multiple sclerosis (MS) have been developed and released to market. These drugs, to varying degrees, reduced the frequency of MS relapses, the accumulation of lesions on MRI, and the progression of disability in randomised controlled trials with follow-up of 2–3 years. The first generation of treatments, beta interferons and glatiramer acetate, also delay a second relapse and thus the risk of conversion to clinically definite MS in patients with a first clinical demyelinating event. (Source: Lancet Neurology)

Continue reading:  

[Comment] New treatments for multiple sclerosis: at what long-term risk?

Leave a Comment

More from category

New sleep system helps profoundly disabled 5-year-old boy with complex care needs to get full night’s sleep
New sleep system helps profoundly disabled 5-year-old boy with complex care needs to get full night’s sleep

A 5-year-old boy, who is profoundly disabled and has complex needs, has been given his first full night’s sleep [Read More]

Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis
Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis

An expert panel is tackling the first revision to the multiple sclerosis diagnostic criteria in 7 years. Among proposed [Read More]

Connecticut State Budget Call to Action
Connecticut State Budget Call to Action

/About-the-Society/News/Connecticut-State-Budget-Call-to-Action [Read More]

A Surge of New Drug Data in Multiple Sclerosis A Surge of New Drug Data in Multiple Sclerosis
A Surge of New Drug Data in Multiple Sclerosis A Surge of New Drug Data in Multiple Sclerosis

Medscape sits down with two neurologists to discuss advances in multiple sclerosis as presented at this year's American [Read More]

Progress on Bills to Address Step Therapy
Progress on Bills to Address Step Therapy

/About-the-Society/News/Progress-on-Bills-to-Address-Step-Therapy [Read More]